Proprietary SDC TechnologyOwning a distinctive antimicrobial chemistry (SDC) provides an enduring competitive asset: it supports product differentiation, licensing potential, and barriers to entry in sanitation markets. Over months, IP-led product advantages can sustain pricing, partner interest, and recurring product sales.
Diverse Institutional End MarketsServing multiple institutional markets (food processing, healthcare, industrial) creates structural demand and reduces single-market exposure. Institutional sanitation buyers often require validated chemistries and recurring purchases, supporting steadier revenue streams and long-term commercial relationships.
Governance Stability & Financing FlexibilityApproval to increase authorized shares and re-election of directors provides durable corporate flexibility: it preserves avenues for future equity raises, strategic transactions, or compensation programs, and signals continued board continuity to execute financing or partnership strategies.